Effectiveness of Cognitive Therapy for Suicide Attempters With Drug Dependence Disorder
Cognitive Therapy for Suicide Attempters With Drug Dependence Disorder
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
Suicide attempts involving drug abuse are a major public health problem. Development of interventions that focus on reducing the suicide attempt rate among drug abusers is a necessity. There is a strong connection between drug abuse and both suicide attempts and completed suicide. As much as 45% of drug abusers have attempted suicide at least once. The rate of completed suicide among drug abusers has been reported to be as much as 30 times the rate for the general population. Unfortunately, there is a lack of empirically supported treatments for reducing suicidal behavior in drug abusers. This study will develop and evaluate the effectiveness of a cognitive therapy intervention for people with a drug dependence disorder who recently attempted suicide.
Participants in this single-blind study will be randomly assigned to one of two treatment groups: cognitive therapy combined with enriched usual care; or enriched usual care alone. An initial baseline assessment will occur within 7 days following the participant's suicide attempt and subsequent medical evaluation at a hospital emergency department. Suicide behavior and ideation, depression, hopelessness, and addiction severity will be assessed. Following the baseline assessment, treatment will begin. The cognitive therapy treatment will be specifically developed to prevent suicide attempts. It will involve the identification of proximal thoughts, images, and core beliefs that were activated prior to the suicide attempt. Cognitive and behavioral strategies will be applied to address the identified thoughts and beliefs. Patients will also learn adaptive ways of coping with stressors. The enriched usual care will entail standard treatments for suicide prevention. Study visits will occur 1, 3, 6, 12, 18, and 24 months following enrollment. Baseline measurements will be repeated at each study visit to evaluate participants' improvement. Participants receiving cognitive therapy will attend approximately 10 weekly or bi-weekly outpatient study visits. Participation will last for 2 years.
For information on a related study, please follow this link:
http://clinicaltrials.gov/show/NCT00149773
Tipo de estudo
Inscrição (Real)
Estágio
- Fase 1
Contactos e Locais
Locais de estudo
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Estados Unidos, 19104
- Psychopathology Research Unit-University of Pennsylvania
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Recent suicide attempt with an emergency department visit within 48 hours of the attempt (suicide attempt is considered to be a potentially self-injurious behavior with a nonfatal outcome for which there is evidence, either explicit or implicit, that the individual intended to kill himself or herself)
- Current DSM-IV diagnosis of a current drug dependence disorder within the past 6 months
Exclusion Criteria:
- Self-mutilating behavior without intent to commit suicide
- An acute, unstable, or severe Axis III disorder that may affect participation
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Outro: Cognitive Therapy
The cognitive therapy intervention for suicide attempters has been designed to provide a brief, timely, flexible intervention that can be incorporated into general and psychiatric inpatient and outpatient services and applied to the population of patients who attempt suicide.
A central feature of the intervention is the adaptation of cognitive therapy to the population of patients who attempt suicide.
The focus of the intervention is the identification of core beliefs and key automatic thoughts that were elicited prior to and during the most recent suicide attempt.
Once these beliefs and thoughts have been articulated, the counselor and patient develop more adaptive responses during an acute suicidal crisis.
|
The cognitive therapy intervention for suicide attempters has been designed to provide a brief, timely, flexible intervention that can be incorporated into general and psychiatric inpatient and outpatient services and applied to the population of patients who attempt suicide.
A central feature of the intervention is the adaptation of cognitive therapy to the population of patients who attempt suicide.
The focus of the intervention is the identification of core beliefs and key automatic thoughts that were elicited prior to and during the most recent suicide attempt.
Once these beliefs and thoughts have been articulated, the counselor and patient develop more adaptive responses during an acute suicidal crisis.
|
|
Outro: Enriched Care
The Enriched Care condition will be used as the treatment comparison condition for this study.
The Enriched Care condition consists of the usual care that patients may obtain in the community as well as the assessment and referral services provided by the case managers.
Participation in the study does not restrict patients in any way in their access to other health care, and all patients in both conditions will be allowed to receive any additional mental health and substance abuse treatment in the community.
|
The Enriched Care condition will be used as the treatment comparison condition for this study.
The Enriched Care condition consists of the usual care that patients may obtain in the community as well as the assessment and referral services provided by the case managers.
Participation in the study does not restrict patients in any way in their access to other health care, and all patients in both conditions will be allowed to receive any additional mental health and substance abuse treatment in the community.
Outros nomes:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Prazo |
|---|---|
|
Suicidal Attempts
Prazo: Months 1, 3, 6, 12, 18, and 24
|
Months 1, 3, 6, 12, 18, and 24
|
Medidas de resultados secundários
Medida de resultado |
Prazo |
|---|---|
|
Suicide Ideation
Prazo: Months 1, 3, 6, 12, 18, and 24
|
Months 1, 3, 6, 12, 18, and 24
|
|
Depression
Prazo: Months 1, 3, 6, 12, 18, and 24
|
Months 1, 3, 6, 12, 18, and 24
|
|
Hopelessness
Prazo: Months 1, 3, 6, 12, 18, and 24
|
Months 1, 3, 6, 12, 18, and 24
|
|
Substance Use
Prazo: Months 1, 3, 6, 12, 18, and 24
|
Months 1, 3, 6, 12, 18, and 24
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- P20MH071905-02 (Concessão/Contrato do NIH dos EUA)
- DSIR 83-ATP (NCT00719979)
- 802439 (Outro identificador: University of Pennsylvania IRB)
- FWA00003616
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .